Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice (Q28260290)

From Wikidata

Revision as of 00:50, 17 January 2017 by Harej (talk | contribs) (‎Created claim: publication date (P577): March 2008, #quickstatements)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

No description defined

Language	Label	Description	Also known as
English	Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice	No description defined

Statements

instance of

scholarly article

0 references

title

Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice (English)

0 references

original language of film or TV show

English

0 references

publication date

March 2008

0 references

published in

Journal of Pharmacology and Experimental Therapeutics

0 references

volume

324

0 references

issue

3

0 references

Identifiers

PubMed publication ID

18065502

0 references

 

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28260290&oldid=431417273"